Fny Investment Advisers, LLC Chembio Diagnostics, Inc. Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 10, 2020
SELL
$3.18 - $15.54 $34,436 - $168,282
-10,829 Closed
0 $0
Q1 2020

Apr 09, 2020
BUY
$2.36 - $5.6 $19,281 - $45,752
8,170 Added 307.26%
10,829 $55,000
Q4 2019

Jan 10, 2020
SELL
$3.94 - $5.76 $3,640 - $5,322
-924 Reduced 25.79%
2,659 $12,000
Q3 2019

Oct 25, 2019
BUY
$4.84 - $7.25 $17,341 - $25,976
3,583 New
3,583 $21,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email